152 related articles for article (PubMed ID: 34110812)
1. Novel Bisubstrate Inhibitors for Protein N-Terminal Acetyltransferase D.
Deng Y; Deng S; Ho YH; Gardner SM; Huang Z; Marmorstein R; Huang R
J Med Chem; 2021 Jun; 64(12):8263-8271. PubMed ID: 34110812
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis for histone H4- and H2A-specific amino-terminal acetylation by NatD.
Magin RS; Liszczak GP; Marmorstein R
Structure; 2015 Feb; 23(2):332-41. PubMed ID: 25619998
[TBL] [Abstract][Full Text] [Related]
3. Development of A Continuous Fluorescence-Based Assay for
Ho YH; Chen L; Huang R
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33435607
[No Abstract] [Full Text] [Related]
4. Effects of Oncohistone Mutations and PTM Crosstalk on the N-Terminal Acetylation Activities of NatD.
Ho YH; Huang R
ACS Chem Biol; 2023 Apr; 18(4):693-700. PubMed ID: 35044762
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Play between Human N-α-acetyltransferase D and H4-mutant Histones: Molecular Dynamics Study.
Rathod SB; Srivastava KR
Curr Protein Pept Sci; 2023; 24(4):339-354. PubMed ID: 36924088
[TBL] [Abstract][Full Text] [Related]
6. New potent bisubstrate inhibitors of histone acetyltransferase p300: design, synthesis and biological evaluation.
Kwie FH; Briet M; Soupaya D; Hoffmann P; Maturano M; Rodriguez F; Blonski C; Lherbet C; Baudoin-Dehoux C
Chem Biol Drug Des; 2011 Jan; 77(1):86-92. PubMed ID: 21118378
[TBL] [Abstract][Full Text] [Related]
7. The human N-alpha-acetyltransferase 40 (hNaa40p/hNatD) is conserved from yeast and N-terminally acetylates histones H2A and H4.
Hole K; Van Damme P; Dalva M; Aksnes H; Glomnes N; Varhaug JE; Lillehaug JR; Gevaert K; Arnesen T
PLoS One; 2011; 6(9):e24713. PubMed ID: 21935442
[TBL] [Abstract][Full Text] [Related]
8. NatD promotes lung cancer progression by preventing histone H4 serine phosphorylation to activate Slug expression.
Ju J; Chen A; Deng Y; Liu M; Wang Y; Wang Y; Nie M; Wang C; Ding H; Yao B; Gui T; Li X; Xu Z; Ma C; Song Y; Kvansakul M; Zen K; Zhang CY; Luo C; Fang M; Huang DCS; Allis CD; Tan R; Zeng CK; Wei J; Zhao Q
Nat Commun; 2017 Oct; 8(1):928. PubMed ID: 29030587
[TBL] [Abstract][Full Text] [Related]
9. Bisubstrate Inhibitors of the MYST HATs Esa1 and Tip60.
Wu J; Xie N; Wu Z; Zhang Y; Zheng YG
Bioorg Med Chem; 2009 Feb; 17(3):1381-6. PubMed ID: 19114310
[TBL] [Abstract][Full Text] [Related]
10. Bisubstrate inhibitors to target histone acetyltransferase 1.
Ngo L; Brown T; Zheng YG
Chem Biol Drug Des; 2019 May; 93(5):865-873. PubMed ID: 30637990
[TBL] [Abstract][Full Text] [Related]
11. Depletion of histone N-terminal-acetyltransferase Naa40 induces p53-independent apoptosis in colorectal cancer cells via the mitochondrial pathway.
Pavlou D; Kirmizis A
Apoptosis; 2016 Mar; 21(3):298-311. PubMed ID: 26666750
[TBL] [Abstract][Full Text] [Related]
12. X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition.
Wolf E; De Angelis J; Khalil EM; Cole PA; Burley SK
J Mol Biol; 2002 Mar; 317(2):215-24. PubMed ID: 11902838
[TBL] [Abstract][Full Text] [Related]
13. Novel bisubstrate analog inhibitors of serotonin N-acetyltransferase: the importance of being neutral.
Zheng W; Cole PA
Bioorg Chem; 2003 Oct; 31(5):398-411. PubMed ID: 12941292
[TBL] [Abstract][Full Text] [Related]
14. N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.
Jonckheere V; Van Damme P
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916271
[TBL] [Abstract][Full Text] [Related]
15. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
[TBL] [Abstract][Full Text] [Related]
16. Histone acetyltransferase NAA40 modulates acetyl-CoA levels and lipid synthesis.
Charidemou E; Tsiarli MA; Theophanous A; Yilmaz V; Pitsouli C; Strati K; Griffin JL; Kirmizis A
BMC Biol; 2022 Jan; 20(1):22. PubMed ID: 35057804
[TBL] [Abstract][Full Text] [Related]
17. Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor.
Poux AN; Cebrat M; Kim CM; Cole PA; Marmorstein R
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14065-70. PubMed ID: 12391296
[TBL] [Abstract][Full Text] [Related]
18. Probing the reaction coordinate of the p300/CBP histone acetyltransferase with bisubstrate analogs.
Karukurichi KR; Cole PA
Bioorg Chem; 2011 Feb; 39(1):42-7. PubMed ID: 21111442
[TBL] [Abstract][Full Text] [Related]
19. NAA40 contributes to colorectal cancer growth by controlling PRMT5 expression.
Demetriadou C; Pavlou D; Mpekris F; Achilleos C; Stylianopoulos T; Zaravinos A; Papageorgis P; Kirmizis A
Cell Death Dis; 2019 Mar; 10(3):236. PubMed ID: 30858358
[TBL] [Abstract][Full Text] [Related]
20. Bisubstrate analogue structure-activity relationships for p300 histone acetyltransferase inhibitors.
Sagar V; Zheng W; Thompson PR; Cole PA
Bioorg Med Chem; 2004 Jun; 12(12):3383-90. PubMed ID: 15158807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
